Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results

Ursula Schmidt-Erfurth, Paolo Lanzetta, Sebastian Wolf, Christian Simader, Erika Tokaji, Stefan Pilz, Annemarie Weisberger, Michael Larsen, MONT BLANC Study Group

118 Citationer (Scopus)

Abstract

To compare the efficacy and safety of same-day verteporfin photodynamic therapy (PDT) and intravitreal ranibizumab combination treatment versus ranibizumab monotherapy in neovascular age-related macular degeneration.
OriginalsprogEngelsk
TidsskriftOphthalmology
Vol/bind119
Udgave nummer5
Sider (fra-til)992-1000
Antal sider9
ISSN0161-6420
DOI
StatusUdgivet - 2012

Fingeraftryk

Dyk ned i forskningsemnerne om 'Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results'. Sammen danner de et unikt fingeraftryk.

Citationsformater